Vertex Pharmaceuticals

Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.
Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.
Yahoo/Zacks.com
Vertex Pharmaceuticals
cystic fibrosis
FDA
priority review
EMA
tezacaftor/ivacaftor
Kalydeco
Flag link:
Vertex wins new Kalydeco approval, ups sales forecast
Vertex wins new Kalydeco approval, ups sales forecast
BioPharma Dive
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Flag link:
Vertex set up for CF monopoly due to data, contracts
Vertex set up for CF monopoly due to data, contracts
BioPharma Dive
Vertex Pharmaceuticals
cystic fibrosis
Flag link:
Biotech Stocks on Fire After Vertex News
Biotech Stocks on Fire After Vertex News
Investopedia
biotech
Vertex Pharmaceuticals
cystic fibrosis
Flag link:
'Just What We Dreamed.' New Vertex Drugs Show Dramatic Benefit Against Cystic Fibrosis
'Just What We Dreamed.' New Vertex Drugs Show Dramatic Benefit Against Cystic Fibrosis
Forbes
Vertex Pharmaceuticals
cystic fibrosis
Orkambi
Kalydeco
Flag link:
Pining for a megadeal, an analyst kicks the tires for another Gilead M&A test drive
Pining for a megadeal, an analyst kicks the tires for another Gilead M&A test drive
Endpoints
M&A
Gilead Sciences
Incyte
Vertex Pharmaceuticals
John Milligan
Flag link:
Prescribed Reading: I/O is the only game in town
Prescribed Reading: I/O is the only game in town
BioPharma Dive
immuno-oncology
Celgene
BeiGene
Endo International
Opana ER
Novartis
Orkambi
Vertex Pharmaceuticals
Merck
Bristol-Myers Squibb
Roche
Opdivo
Keytruda
Orencia
Flag link:
Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul
Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul
Bloomberg
rare disease
healthcare reform
Shire
Jazz Pharmaceuticals
Sanofi
Roche
Biogen
Alexion
Vertex Pharmaceuticals
Flag link:
3 Reasons Why Gilead Sciences Shouldn't Buy Vertex Pharmaceuticals
3 Reasons Why Gilead Sciences Shouldn't Buy Vertex Pharmaceuticals
Motley Fool
Gilead Sciences
Vertex Pharmaceuticals
Flag link:
Gilead's best M&A option? It's not oncology—it's Vertex, analyst insists
Gilead's best M&A option? It's not oncology—it's Vertex, analyst insists
Fierce Pharma
Gilead Sciences
M&A
Vertex Pharmaceuticals
Flag link:
Gilead buy Vertex? A golden oldie in the M&A buzz circuit gets fresh air time
Gilead buy Vertex? A golden oldie in the M&A buzz circuit gets fresh air time
Endpoints
Gilead Sciences
Vertex Pharmaceuticals
M&A
Flag link:
Is Vertex Pharmaceuticals Running Out of Steam or Taking a Breather?
Is Vertex Pharmaceuticals Running Out of Steam or Taking a Breather?
Motley Fool
Vertex Pharmaceuticals
cystic fibrosis
Flag link:
Inside Vertex Pharmaceuticals’ Clinical Pipeline
Inside Vertex Pharmaceuticals’ Clinical Pipeline
Market Realist
Vertex Pharmaceuticals
Tezacaftor-Ivacaftor
cystic fibrosis
Flag link:
Celgene, Regeneron and Vertex execs, NIH chief head to White House as threat of Trump funding cuts looms
Celgene, Regeneron and Vertex execs, NIH chief head to White House as threat of Trump funding cuts looms
Fierce Biotech
biotech
Celgene
Regeneron
Vertex Pharmaceuticals
NIH
Donald Trump
Flag link:
Trump invites ​Vertex CEO to White House for biotech summit
Trump invites ​Vertex CEO to White House for biotech summit
Bizjournals.com
Donald Trump
Pharma CEOs
Vertex Pharmaceuticals
Jeffrey Leiden
Flag link:
​Vertex at odds with religious investors over lobbying disclosures
​Vertex at odds with religious investors over lobbying disclosures
Bizjournals.com
Vertex Pharmaceuticals
lobbying
religion
Flag link:
​Vertex CEO's compensation, stock value fell in 2016
​Vertex CEO's compensation, stock value fell in 2016
Bizjournals.com
Vertex Pharmaceuticals
Pharma CEOs
executive pay
Flag link:
Vertex Pharma shares jump more than 20% on cystic fibrosis study results
Vertex Pharma shares jump more than 20% on cystic fibrosis study results
Marketwatch
Vertex Pharmaceuticals
cystic fibrosis
tezacaftor
Kalydeco
clinical trials
Flag link:
A Review Of Concert's Filed PRE 14A: The CTP-656 Saga May Not Be Done Yet
A Review Of Concert's Filed PRE 14A: The CTP-656 Saga May Not Be Done Yet
Seeking Alpha
Concert Pharmaceuticals
CTP-656
cystic fibrosis
Kalydeco
Vertex Pharmaceuticals
Flag link:
Concert rebuffed $250M buyout offer from Vertex before CF drug deal
Concert rebuffed $250M buyout offer from Vertex before CF drug deal
Bizjournals.com
Concert Pharmaceuticals
Vertex Pharmaceuticals
M&A
cystic fibrosis
CTP-656
Kalydeco
Flag link: